GRDN Guardian Pharmacy Services Earnings and EPS analysis

Relative Growth: Rel. Growth: 26

Relative Strength: Rel. Strength: 80

Relative Valuation: Rel. Valuation: 41

Relative Profitability: Rel. Profitability: 78

EPS in 2026 (TTM): $0.85

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the EPS for the trailing twelve months is $0.85. Guardian Pharmacy Services's EPS for 2025 amounted to $0.79, marking an increase from -$1.77 in 2024. During the quarterly period ending on Mar 31, 2026, GRDN's EPS stood at $0.21.

GRDN earnings history

Historical annual and quarterly earnings per share (EPS) data for Guardian Pharmacy Services

EPS (TTM)

$0.85

EPS Growth YoY (Quarterly)

40%

EPS (Quarterly)

$0.21

EPS Growth (Quarterly)

-36.4%

Guardian Pharmacy Services had an annual EPS of $0.79, indicating an increase of 144.6% from -$1.77 in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $0.21, indicating a 40% increase from the same quarter last year. GRDN's 12-month EPS stands at $0.85 as of March 2026.

GRDN earnings chart

GRDN EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

40%

EPS growth YoY

144.6%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Guardian Pharmacy Services has registered an increase in EPS of 40% during the last 12 months (YoY, quarterly).

GRDN Earnings Waterfall

Breakdown of revenue, profit and net income for Guardian Pharmacy Services

GRDN Earnings vs Peers

What are the earnings of GRDN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
MCK Mckesson Corp	19.63	49.1%	15.2%	N/A
COR Cencora Inc.	20.6	5.5%	-0.5%	N/A
HSIC Henry Schein Inc	22.92	7.2%	-5.9%	3.1%
CAH Cardinal Health Inc	30.67	86.2%	N/A	N/A
CVS CVS HEALTH Corp	40.87	-61.9%	-24.8%	-23.9%
GRDN Guardian Pharmacy Services Inc.	48.07	144.6%	N/A	N/A
ACH Accendra Health Inc.	N/A	-202.5%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.